R&D and Product Engineering in Global Pharmaceutical Companies

Authors

  • Sabina Riboldazzi

DOI:

https://doi.org/10.4468/2015.2.05riboldazzi

Keywords:

Global Markets, Pharmaceutical Companies, Innovation, R&D processes, Drug Discovery, Product Engineering

Abstract

In the global pharmaceutical market, innovation and imitation processes play a key role in companies’ development policies. Through the analysis of the main pharmaceutical companies (originator and generic pharmaceutical companies), this paper aims to identify features that qualify companies themselves, with a particular focus on new product R&D processes.

Author Biography

Sabina Riboldazzi

University of Milan-Bicocca

Downloads

Published

23-06-2015

How to Cite

Riboldazzi, S. (2015). R&D and Product Engineering in Global Pharmaceutical Companies. Symphonya. Emerging Issues in Management, (2), 57–74. https://doi.org/10.4468/2015.2.05riboldazzi

Issue

No. 2 (2015): Design Management, Product Engineering and Global Competition

Section

Articles

License

The authors retain all rights to the original work without any restrictions.

License for Published Contents

Licenza Creative Commons
You are free to copy, distribute and transmit the work, and to adapt the work. You must attribute the work in the manner specified by the author or licensor (but not in any way that suggests that they endorse you or your use of the work).

Licence scheme | Legal code

License for Metadata

Licenza Creative Commons
Symphonya published articles metadata are dedicated to the public domain by waiving all publisher's rights to the work worldwide under copyright law, including all related and neighboring rights, to the extent allowed by law.
You can copy, modify, distribute and perform the work, even for commercial purposes, all without asking permission.

Licence scheme | Legal code